Document is current
Any future updates will be listed below
-
Authors
Huynh, Thao Ngoc
Shukla, Siddharth
Reigan, Philip
Parker, Roy
-
Funding
Funding for this research was provided by:
Howard Hughes Medical Institute
U.S. Department of Defense (W81XWH2110447)
- License Information
-
More Information
Article History
Received: 18 October 2022
Accepted: 21 March 2023
First Online: 31 March 2023
Competing interests
: R.P. is a consultant for Third Rock Ventures and a co-founder of Faze Medicines. Other authors declare no competing interests.
